Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 40 entries
Sorted by: Best Match Show Resources per page
β2-AGONISTS IN CHILDHOOD ASTHMA.

Journal of biological regulators and homeostatic agents

Miraglia Del Giudice M, Campana G, Galdo F, De Vivo D, Cuppari C, Coronella A, Maiello N.
PMID: 26634602
J Biol Regul Homeost Agents. 2015 Apr-Jun;29(2):137-41.

β2-agonists reduce airflow limitation by improving airway diameter as a consequence of a direct action on airway smooth muscle. β;2-agonists can be broadly classified according to their duration of action: short-acting β2-agonists (SABAs), including albuterol, terbutaline and fenoterol, have...

Cite
Miraglia Del Giudice M, Campana G, Galdo F, et al. β2-AGONISTS IN CHILDHOOD ASTHMA. J Biol Regul Homeost Agents. 2015;29(2):137-41
Miraglia Del Giudice, M., Campana, G., Galdo, F., De Vivo, D., Cuppari, C., Coronella, A., & Maiello, N. (2015). β2-AGONISTS IN CHILDHOOD ASTHMA. Journal of biological regulators and homeostatic agents, 29(2), 137-41.
Miraglia Del Giudice, M, et al. "β2-AGONISTS IN CHILDHOOD ASTHMA." Journal of biological regulators and homeostatic agents vol. 29,2 (2015): 137-41.
Miraglia Del Giudice M, Campana G, Galdo F, De Vivo D, Cuppari C, Coronella A, Maiello N. β2-AGONISTS IN CHILDHOOD ASTHMA. J Biol Regul Homeost Agents. 2015 Apr-Jun;29(2):137-41. PMID: 26634602.
Copy Download .nbib Format: NLM
The Effects of β (2) -Adrenoreceptor Activation on the Contractility, Ca-Signals and Nitric Oxide Production in the Mouse Atria.

Acta naturae

Odnoshivkina YG, Petrov AM, Zefirov AL.
PMID: 22649689
Acta Naturae. 2011 Apr;3(2):103-12.

The effects of the selective β(2)-adrenoreceptor agonist (fenoterol) on the functioning of mouse atrial were studied using both tensometry and fluorescent methods. It has been demonstrated that with the use of a high concentration of fenoterol (in the range...

Cite
Odnoshivkina YG, Petrov AM, Zefirov AL. The Effects of β (2) -Adrenoreceptor Activation on the Contractility, Ca-Signals and Nitric Oxide Production in the Mouse Atria. Acta Naturae. 2011;3(2):103-12
Odnoshivkina, Y. G., Petrov, A. M., & Zefirov, A. L. (2011). The Effects of β (2) -Adrenoreceptor Activation on the Contractility, Ca-Signals and Nitric Oxide Production in the Mouse Atria. Acta naturae, 3(2), 103-12.
Odnoshivkina, Yu G, et al. "The Effects of β (2) -Adrenoreceptor Activation on the Contractility, Ca-Signals and Nitric Oxide Production in the Mouse Atria." Acta naturae vol. 3,2 (2011): 103-12.
Odnoshivkina YG, Petrov AM, Zefirov AL. The Effects of β (2) -Adrenoreceptor Activation on the Contractility, Ca-Signals and Nitric Oxide Production in the Mouse Atria. Acta Naturae. 2011 Apr;3(2):103-12. PMID: 22649689; PMCID: PMC3347572.
Copy Download .nbib Format: NLM
Preparation and evaluation of fenoterol hydrobromide suppositories.

Drug discoveries & therapeutics

Ghorab D, Refai H, Tag R.
PMID: 22466443
Drug Discov Ther. 2011 Dec;5(6):311-8. doi: 10.5582/ddt.2011.v5.6.311.

Fenoterol HBr is a bronchodilator known to be subject to first pass effect after oral administration. The aim of this study was to prepare and evaluate fenoterol HBr suppositories. Suppositories were prepared by a fusion method using different fatty...

Cite
Ghorab D, Refai H, Tag R. Preparation and evaluation of fenoterol hydrobromide suppositories. Drug Discov Ther. 2011;5(6):311-8doi: 10.5582/ddt.2011.v5.6.311.
Ghorab, D., Refai, H., & Tag, R. (2011). Preparation and evaluation of fenoterol hydrobromide suppositories. Drug discoveries & therapeutics, 5(6), 311-8. https://doi.org/10.5582/ddt.2011.v5.6.311
Ghorab, D, et al. "Preparation and evaluation of fenoterol hydrobromide suppositories." Drug discoveries & therapeutics vol. 5,6 (2011): 311-8. doi: https://doi.org/10.5582/ddt.2011.v5.6.311
Ghorab D, Refai H, Tag R. Preparation and evaluation of fenoterol hydrobromide suppositories. Drug Discov Ther. 2011 Dec;5(6):311-8. doi: 10.5582/ddt.2011.v5.6.311. PMID: 22466443.
Copy Download .nbib Format: NLM
A prospective study of adverse drug reactions as a cause of admission to a paediatric hospital.

British journal of clinical pharmacology

Martínez-Mir I, García-López M, Palop V, Ferrer JM, Estañ L, Rubio E, Morales-Olivas FJ.
PMID: 8877022
Br J Clin Pharmacol. 1996 Sep;42(3):319-24. doi: 10.1046/j.1365-2125.1996.04076.x.
Free PMC Article

1. A total of 512 consecutive paediatric hospital admissions of children 2 years old or less were evaluated to assess the extent and pattern of admission caused by suspected adverse drug reactions (ADRs). the proportion of suspected ADRs related...

Cite
Martínez-Mir I, García-López M, Palop V, et al. A prospective study of adverse drug reactions as a cause of admission to a paediatric hospital. Br J Clin Pharmacol. 1996;42(3):319-24doi: 10.1046/j.1365-2125.1996.04076.x.
Martínez-Mir, I., García-López, M., Palop, V., Ferrer, J. M., Estañ, L., Rubio, E., & Morales-Olivas, F. J. (1996). A prospective study of adverse drug reactions as a cause of admission to a paediatric hospital. British journal of clinical pharmacology, 42(3), 319-24. https://doi.org/10.1046/j.1365-2125.1996.04076.x
Martínez-Mir, I, et al. "A prospective study of adverse drug reactions as a cause of admission to a paediatric hospital." British journal of clinical pharmacology vol. 42,3 (1996): 319-24. doi: https://doi.org/10.1046/j.1365-2125.1996.04076.x
Martínez-Mir I, García-López M, Palop V, Ferrer JM, Estañ L, Rubio E, Morales-Olivas FJ. A prospective study of adverse drug reactions as a cause of admission to a paediatric hospital. Br J Clin Pharmacol. 1996 Sep;42(3):319-24. doi: 10.1046/j.1365-2125.1996.04076.x. PMID: 8877022; PMCID: PMC2042676.
Copy Download .nbib Format: NLM
Molecular basis for stereoselective transport of fenoterol by the organic cation transporters 1 and 2.

Biochemical pharmacology

Gebauer L, Arul Murugan N, Jensen O, Brockmöller J, Rafehi M.
PMID: 34902340
Biochem Pharmacol. 2021 Dec 10;197:114871. doi: 10.1016/j.bcp.2021.114871. Epub 2021 Dec 10.

Stereoselectivity is important in many pharmacological processes but its impact on drug membrane transport is scarcely understood. Recent studies showed strong stereoselective effects in the cellular uptake of fenoterol by the organic cation transporters OCT1 and OCT2. To provide...

Cite
Gebauer L, Arul Murugan N, Jensen O, et al. Molecular basis for stereoselective transport of fenoterol by the organic cation transporters 1 and 2. Biochem Pharmacol. 2021;197:114871doi: 10.1016/j.bcp.2021.114871.
Gebauer, L., Arul Murugan, N., Jensen, O., Brockmöller, J., & Rafehi, M. (2021). Molecular basis for stereoselective transport of fenoterol by the organic cation transporters 1 and 2. Biochemical pharmacology, 197114871. https://doi.org/10.1016/j.bcp.2021.114871
Gebauer, Lukas, et al. "Molecular basis for stereoselective transport of fenoterol by the organic cation transporters 1 and 2." Biochemical pharmacology vol. 197 (2021): 114871. doi: https://doi.org/10.1016/j.bcp.2021.114871
Gebauer L, Arul Murugan N, Jensen O, Brockmöller J, Rafehi M. Molecular basis for stereoselective transport of fenoterol by the organic cation transporters 1 and 2. Biochem Pharmacol. 2021 Dec 10;197:114871. doi: 10.1016/j.bcp.2021.114871. Epub 2021 Dec 10. PMID: 34902340.
Copy Download .nbib Format: NLM
Molecular basis for stereoselective transport of fenoterol by the organic cation transporters 1 and 2.

Biochemical pharmacology

Gebauer L, Arul Murugan N, Jensen O, Brockmöller J, Rafehi M.
PMID: 34902340
Biochem Pharmacol. 2021 Dec 10;197:114871. doi: 10.1016/j.bcp.2021.114871. Epub 2021 Dec 10.

Stereoselectivity is important in many pharmacological processes but its impact on drug membrane transport is scarcely understood. Recent studies showed strong stereoselective effects in the cellular uptake of fenoterol by the organic cation transporters OCT1 and OCT2. To provide...

Cite
Gebauer L, Arul Murugan N, Jensen O, et al. Molecular basis for stereoselective transport of fenoterol by the organic cation transporters 1 and 2. Biochem Pharmacol. 2021;197:114871doi: 10.1016/j.bcp.2021.114871.
Gebauer, L., Arul Murugan, N., Jensen, O., Brockmöller, J., & Rafehi, M. (2021). Molecular basis for stereoselective transport of fenoterol by the organic cation transporters 1 and 2. Biochemical pharmacology, 197114871. https://doi.org/10.1016/j.bcp.2021.114871
Gebauer, Lukas, et al. "Molecular basis for stereoselective transport of fenoterol by the organic cation transporters 1 and 2." Biochemical pharmacology vol. 197 (2021): 114871. doi: https://doi.org/10.1016/j.bcp.2021.114871
Gebauer L, Arul Murugan N, Jensen O, Brockmöller J, Rafehi M. Molecular basis for stereoselective transport of fenoterol by the organic cation transporters 1 and 2. Biochem Pharmacol. 2021 Dec 10;197:114871. doi: 10.1016/j.bcp.2021.114871. Epub 2021 Dec 10. PMID: 34902340.
Copy Download .nbib Format: NLM
Comparison efficacy of randomized nebulized magnesium sulfate and ipratropium bromide/fenoterol in children with moderate to severe asthma exacerbation.

Asian Pacific journal of allergy and immunology

Wongwaree S, Daengsuwan T.
PMID: 31421659
Asian Pac J Allergy Immunol. 2019 Aug 18; doi: 10.12932/AP-190717-0118. Epub 2019 Aug 18.

BACKGROUND: In Thailand, nebulized ipratropium bromide/fenoterol, is commonly used in addition to salbutamol for severe asthma exacerbation. Recently, nebulized MgSO4 is indicated in GINA 2015 as an additive treatment for severe cases. However, there is limited data showed the...

Cite
Wongwaree S, Daengsuwan T. Comparison efficacy of randomized nebulized magnesium sulfate and ipratropium bromide/fenoterol in children with moderate to severe asthma exacerbation. Asian Pac J Allergy Immunol. 2019;doi: 10.12932/AP-190717-0118.
Wongwaree, S., & Daengsuwan, T. (2019). Comparison efficacy of randomized nebulized magnesium sulfate and ipratropium bromide/fenoterol in children with moderate to severe asthma exacerbation. Asian Pacific journal of allergy and immunology, . https://doi.org/10.12932/AP-190717-0118
Wongwaree, Siriporn, and Daengsuwan, Tassalapa. "Comparison efficacy of randomized nebulized magnesium sulfate and ipratropium bromide/fenoterol in children with moderate to severe asthma exacerbation." Asian Pacific journal of allergy and immunology vol. (2019). doi: https://doi.org/10.12932/AP-190717-0118
Wongwaree S, Daengsuwan T. Comparison efficacy of randomized nebulized magnesium sulfate and ipratropium bromide/fenoterol in children with moderate to severe asthma exacerbation. Asian Pac J Allergy Immunol. 2019 Aug 18; doi: 10.12932/AP-190717-0118. Epub 2019 Aug 18. PMID: 31421659.
Copy Download .nbib Format: NLM
Clinical efficacy and safety of the combination of ipratropium bromide and fenoterol inhaled via the Respimat Soft Mist inhaler for relief of airflow obstruction.

Expert review of respiratory medicine

Vincken W.
PMID: 20477218
Expert Rev Respir Med. 2008 Feb;2(1):11-26. doi: 10.1586/17476348.2.1.11.

Bronchodilators are key drugs in symptomatic as well as maintenance treatment of obstructive lung diseases such as chronic obstructive pulmonary disease and asthma. The short-acting anticholinergic ipratropium bromide and the short-acting beta(2)-adrenergic receptor agonist fenoterol hydrobromide have been available...

Cite
Vincken W. Clinical efficacy and safety of the combination of ipratropium bromide and fenoterol inhaled via the Respimat Soft Mist inhaler for relief of airflow obstruction. Expert Rev Respir Med. 2008;2(1):11-26doi: 10.1586/17476348.2.1.11.
Vincken, W. (2008). Clinical efficacy and safety of the combination of ipratropium bromide and fenoterol inhaled via the Respimat Soft Mist inhaler for relief of airflow obstruction. Expert review of respiratory medicine, 2(1), 11-26. https://doi.org/10.1586/17476348.2.1.11
Vincken, Walter. "Clinical efficacy and safety of the combination of ipratropium bromide and fenoterol inhaled via the Respimat Soft Mist inhaler for relief of airflow obstruction." Expert review of respiratory medicine vol. 2,1 (2008): 11-26. doi: https://doi.org/10.1586/17476348.2.1.11
Vincken W. Clinical efficacy and safety of the combination of ipratropium bromide and fenoterol inhaled via the Respimat Soft Mist inhaler for relief of airflow obstruction. Expert Rev Respir Med. 2008 Feb;2(1):11-26. doi: 10.1586/17476348.2.1.11. PMID: 20477218.
Copy Download .nbib Format: NLM
Safety of bronchodilator reversibility test in elderly subjects: a prospective study.

Postepy dermatologii i alergologii

Dor-Wojnarowska A, Parużyńska A, Kulczak A, Majewska-Pulsakowska M, Szymala-Pędzik M, Machaj Z, Sobieszczańska M, Poręba M.
PMID: 34408593
Postepy Dermatol Alergol. 2021 Apr;38(2):256-261. doi: 10.5114/ada.2020.92515. Epub 2020 Feb 19.

INTRODUCTION: The reversibility test measures an increase in ventilation parameters after the administration of 400 mg of a short-acting β-agonist (SABA). It is worth noting that a typical dosage, applied as a rescue medicine for bronchospastic dyspnoea, is significantly...

Cite
Dor-Wojnarowska A, Parużyńska A, Kulczak A, et al. Safety of bronchodilator reversibility test in elderly subjects: a prospective study. Postepy Dermatol Alergol. 2020;38(2):256-261doi: 10.5114/ada.2020.92515.
Dor-Wojnarowska, A., Parużyńska, A., Kulczak, A., Majewska-Pulsakowska, M., Szymala-Pędzik, M., Machaj, Z., Sobieszczańska, M., & Poręba, M. (2021). Safety of bronchodilator reversibility test in elderly subjects: a prospective study. Postepy dermatologii i alergologii, 38(2), 256-261. https://doi.org/10.5114/ada.2020.92515
Dor-Wojnarowska, Anna, et al. "Safety of bronchodilator reversibility test in elderly subjects: a prospective study." Postepy dermatologii i alergologii vol. 38,2 (2021): 256-261. doi: https://doi.org/10.5114/ada.2020.92515
Dor-Wojnarowska A, Parużyńska A, Kulczak A, Majewska-Pulsakowska M, Szymala-Pędzik M, Machaj Z, Sobieszczańska M, Poręba M. Safety of bronchodilator reversibility test in elderly subjects: a prospective study. Postepy Dermatol Alergol. 2021 Apr;38(2):256-261. doi: 10.5114/ada.2020.92515. Epub 2020 Feb 19. PMID: 34408593; PMCID: PMC8362750.
Copy Download .nbib Format: NLM
Isobutyrylcarnitine as a Biomarker of OCT1 Activity and Interspecies Differences in its Membrane Transport.

Frontiers in pharmacology

Jensen O, Matthaei J, Klemp HG, Meyer MJ, Brockmöller J, Tzvetkov MV.
PMID: 34040533
Front Pharmacol. 2021 May 10;12:674559. doi: 10.3389/fphar.2021.674559. eCollection 2021.

Genome-wide association studies have identified an association between isobutyrylcarnitine (IBC) and organic cation transporter 1 (OCT1) genotypes. Higher IBC blood concentrations in humans with active OCT1 genotypes and experimental studies with mouse OCT1 suggested an OCT1-mediated efflux of IBC....

Cite
Jensen O, Matthaei J, Klemp HG, et al. Isobutyrylcarnitine as a Biomarker of OCT1 Activity and Interspecies Differences in its Membrane Transport. Front Pharmacol. 2021;12:674559doi: 10.3389/fphar.2021.674559.
Jensen, O., Matthaei, J., Klemp, H. G., Meyer, M. J., Brockmöller, J., & Tzvetkov, M. V. (2021). Isobutyrylcarnitine as a Biomarker of OCT1 Activity and Interspecies Differences in its Membrane Transport. Frontiers in pharmacology, 12674559. https://doi.org/10.3389/fphar.2021.674559
Jensen, Ole, et al. "Isobutyrylcarnitine as a Biomarker of OCT1 Activity and Interspecies Differences in its Membrane Transport." Frontiers in pharmacology vol. 12 (2021): 674559. doi: https://doi.org/10.3389/fphar.2021.674559
Jensen O, Matthaei J, Klemp HG, Meyer MJ, Brockmöller J, Tzvetkov MV. Isobutyrylcarnitine as a Biomarker of OCT1 Activity and Interspecies Differences in its Membrane Transport. Front Pharmacol. 2021 May 10;12:674559. doi: 10.3389/fphar.2021.674559. eCollection 2021. PMID: 34040533; PMCID: PMC8141810.
Copy Download .nbib Format: NLM
Fenoterol and dobutamine as SARS-CoV-2 main protease inhibitors: A virtual screening study.

Journal of molecular structure

Bolelli K, Ertan-Bolelli T, Unsalan O, Altunayar-Unsalan C.
PMID: 33071354
J Mol Struct. 2021 Mar 15;1228:129449. doi: 10.1016/j.molstruc.2020.129449. Epub 2020 Oct 13.

Global health is under heavy threat by a worldwide pandemic caused by a new type of coronavirus (COVID-19) since its rapid spread in China in 2019 [1]. Currently, there are no approved specific drugs and effective treatment for COVID-19...

Cite
Bolelli K, Ertan-Bolelli T, Unsalan O, et al. Fenoterol and dobutamine as SARS-CoV-2 main protease inhibitors: A virtual screening study. J Mol Struct. 2020;1228:129449doi: 10.1016/j.molstruc.2020.129449.
Bolelli, K., Ertan-Bolelli, T., Unsalan, O., & Altunayar-Unsalan, C. (2021). Fenoterol and dobutamine as SARS-CoV-2 main protease inhibitors: A virtual screening study. Journal of molecular structure, 1228129449. https://doi.org/10.1016/j.molstruc.2020.129449
Bolelli, Kayhan, et al. "Fenoterol and dobutamine as SARS-CoV-2 main protease inhibitors: A virtual screening study." Journal of molecular structure vol. 1228 (2021): 129449. doi: https://doi.org/10.1016/j.molstruc.2020.129449
Bolelli K, Ertan-Bolelli T, Unsalan O, Altunayar-Unsalan C. Fenoterol and dobutamine as SARS-CoV-2 main protease inhibitors: A virtual screening study. J Mol Struct. 2021 Mar 15;1228:129449. doi: 10.1016/j.molstruc.2020.129449. Epub 2020 Oct 13. PMID: 33071354; PMCID: PMC7550866.
Copy Download .nbib Format: NLM
Validation of Fenoterol to Study β2-Adrenoceptor Function in the Rat Urinary Bladder.

Pharmacology

Erdogan BR, Yesilyurt ZE, Arioglu-Inan E, Michel MC.
PMID: 34781292
Pharmacology. 2021 Nov 15;1-6. doi: 10.1159/000519720. Epub 2021 Nov 15.

Fenoterol is a β2-adrenoceptor (AR)-selective agonist that is commonly used to investigate relaxation responses mediated by β2-AR in smooth muscle preparations. Some data have questioned this because fenoterol had low potency in the rat urinary bladder when a muscarinic...

Cite
Erdogan BR, Yesilyurt ZE, Arioglu-Inan E, et al. Validation of Fenoterol to Study β2-Adrenoceptor Function in the Rat Urinary Bladder. Pharmacology. 2021;1-6doi: 10.1159/000519720.
Erdogan, B. R., Yesilyurt, Z. E., Arioglu-Inan, E., & Michel, M. C. (2021). Validation of Fenoterol to Study β2-Adrenoceptor Function in the Rat Urinary Bladder. Pharmacology, 1-6. https://doi.org/10.1159/000519720
Erdogan, Betül Rabia, et al. "Validation of Fenoterol to Study β2-Adrenoceptor Function in the Rat Urinary Bladder." Pharmacology vol. (2021): 1-6. doi: https://doi.org/10.1159/000519720
Erdogan BR, Yesilyurt ZE, Arioglu-Inan E, Michel MC. Validation of Fenoterol to Study β2-Adrenoceptor Function in the Rat Urinary Bladder. Pharmacology. 2021 Nov 15;1-6. doi: 10.1159/000519720. Epub 2021 Nov 15. PMID: 34781292.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 40 entries